BIIL-260

4-((3-((4-(2-(4-(4-(4-(4-羟基苯)丙-2-基)苯氧基)甲基)苯甲基)氧)苯并咪酰胺Chemical Name: 4-[3-[4-[1-(4-Hydroxyphenyl)-1-methylethyl]phenoxy]methyl]benzyloxy]benzenecarboximidamide
CAS No. 204974-93-6
项目整合开发状态: Preclinical
项目研究机构: Boehringer Ingelheim (Originator)
合成路线:Nitrile (I) was converted to hydroxamic acid (II) upon treatment with hydroxylamine.Further hydrogenation in the presence of Raney-nickel provided amidine (III),which was finally condensed with ethyl chloroformate to yield the title compound.

合成路线:Nitrile (I) was converted to hydroxamic acid (II) upon treatment with hydroxylamine.Further hydrogenation in the presence of Raney-nickel provided the target amidine.
📌 参考资料/链接:
参考文献标题:Substd.benzamidines,their production and their use as medicaments
文献作者:Anderskewitz,R.; Schromm,K.; Renth,E.-O.; Birke,F.; F黦ner,A.; Heuer,H.; Meade,C.(Boehringer Ingelheim GmbH)
参考来源:DE 4424713; EP 0770059; JP 1998502645; US 5731332; WO 9602497

📄 详细内容


产品链接: CAS No. 204974-93-6››